title: Relationship of volumetric bone mineral density and structural parameters with ERalpha gene polymorphisms.
abstract: Bone mineral density (BMD) contributes to bone strength, and methods for clinical assessment of bone quality characteristics beyond what can be gathered by BMD are awaited. Peripheral quantitative computed tomography (pQCT) allows for separate assessments of cortical and trabecular bone, providing information on bone geometry. Previous studies examining the relationship between estrogen receptor alpha (ERalpha) gene polymorphisms and BMD have been performed in large populations. However, only limited information is available on the possible segregation of ERalpha gene polymorphisms with bone structural properties. The aim of our study was to evaluate the association of XbaI and PvuII ERalpha gene polymorphisms with QCT parameters. We studied 900 subjects (541 women, 449 men) participating to the InCHIANTI study. By tibial pQCT we evaluated trabecular volumetric BMD, cortical volumetric BMD, cortical bone area, and cortical thickness (CtTh). Subjects were genotyped for ERalpha gene PvuII and XbaI polymorphisms. Analysis of variance was used for statistical analysis. Male subjects with PP and XX genotypes had higher geometric parameters, and female subjects with XX and PP genotypes showed higher densitometric parameters than other genotypes; however, the differences did not reach statistical significance. After adjustment for potential confounders, we found a significant (P = 0.002) CtTh difference across PvuII polymorphism in male subjects, with higher CtTh values in PP genotypes with respect to Pp and pp genotypes. These results show a relationship between the presence of the P allele and higher values of CtTh in male subjects, indicating for ERalpha a role in the control of tibial bone geometry.
authors.affiliation: Department of Internal Medicine, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Cepollaro
authors.forename: F
authors.initials: F
authors.lastname: Lauretani
authors.forename: A
authors.initials: A
authors.lastname: Gozzini
authors.forename: L
authors.initials: L
authors.lastname: Masi
authors.forename: A
authors.initials: A
authors.lastname: Falchetti
authors.forename: F
authors.initials: F
authors.lastname: Del Monte
authors.forename: S
authors.initials: S
authors.lastname: Carbonell-Sala
authors.forename: A
authors.initials: A
authors.lastname: Tanini
authors.forename: A M
authors.initials: AM
authors.lastname: Corsi
authors.forename: S
authors.initials: S
authors.lastname: Bandinelli
authors.forename: L
authors.initials: L
authors.lastname: Ferrucci
authors.forename: M L
authors.initials: ML
authors.lastname: Brandi
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density / Q000235:genetics*; D047628:Estrogen Receptor alpha / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D007558:Italy; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D012727:Sex Characteristics; D012737:Sex Factors; D013977:Tibia / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology; D014057:Tomography, X-Ray Computed
chemical_list: D047628:Estrogen Receptor alpha